CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.
August 14th 2023
Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.
Injectable Tecentriq Is Efficacious, Reduces Treatment Time for Lung Cancer
August 2nd 2022Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.
Targeting a Specific Genetic Mutation May Change Treatment Landscape for Non-Small Cell Lung Cancer
April 21st 2021Patients with non-small cell lung cancer and a KRAS G12C genetic mutation may benefit from treatment with an inhibitor targeting that mutation, although more research is needed to learn why more patients are not responding to the drug.
Cell-Based Therapies May ‘Level the Playing Field’ in Non-Small Cell Lung Cancer
April 20th 2021Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.